David W. Dodick, MD
Advertisement
Director, Concussion and Headache Programs, Mayo Clinic; Chair, American Brain Foundation, IHS-Global Patient Advocacy Coalition
Articles by David W. Dodick, MD
Here: highlights from a systematic review that these authors view as a substantial step forward in establishing an evidence-based approach to migraine treatment in the acute care setting.
Advertisement
Latest Updated Articles
Therapies in Development for Acute MigraineOctober 30th 2020
Gepants for Acute Migraine: Safety & Efficacy DataOctober 30th 2020
Treating Acute Migraine in the Community SettingOctober 30th 2020
Advances in the Treatment of Acute MigraineOctober 30th 2020
Real-World Experience With Gepants for Acute MigraineOctober 30th 2020
Ubrogepant: Treatment for Acute MigraineOctober 30th 2020
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
The Expanding Role of Blood-Based Biomarkers in MS Care
2
Phase 2 ACUITY Analysis Shows Privosegtor Associated With Smaller Early NfL and GFAP Increases in Acute Optic Neuritis
3
Blood-Based Biomarkers for Monitoring Treatment Response in Multiple Sclerosis
4
AI Is Getting More Out of MS Data, but Clinical Use Lags Behind
5